Myeloma and Related Diseases Registry (MRDR)

Thanks to MRDR participants and contributing sites who provided data for the latest MRDR publication! - 'Māori and Pacific Peoples with multiple myeloma in New Zealand are younger and have inferior survival compared to other ethnicities: A study from the ANZ MRDR'. Access the paper here: https://doi.org/10.1016/j.clml.2022.04.004

Find out more

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
5370

Patients accrued

3605

Patients with multiple myeloma

56

Number of approved sites

572

Biobank participants

Latest news

Rare Disease Day, Monday 28 Feb!
24 Feb 2022

Thanks to those who contribute to improving care, and providing support for people living with myeloma & related diseases!

Read more
MRFF grant for MY-PROMPT-2 trial!
11 Jan 2022

MY-PROMPT-2 project funded!

Read more
5000 patients registered!!
15 Dec 2021

The MRDR reached 5000 registered participants!

Read more
Join us at the Asia-Pacific MRDR Investigators’ meeting!
10 Dec 2021

All are welcome to the Asia-Pacific MRDR Investigators' meeting, Fri, 17 Dec, 4pm AEDT!

Read more

Participating organisations